CHROMagar Candida Plus
Overview
Candida auris is an emerging fungal pathogen first identified in Japan in 2005. This yeast can cause severe, potentially life-threatening infections, often resistant to multiple antifungal drugs. C. auris exists in at least four distinct genetic groups (clades). Strains from some clades are more likely to cause severe infections. Skin colonization is a significant concern in C. auris outbreaks, highlighting the importance of thorough patient screening to prevent further spread. Until CHROMagar™ Candida was the primary rapid culture-based method for screening for Candida species.
Intended Use
CHROMagar™ Candida Plus is a specialized growth medium that enables the direct detection, differentiation, and presumptive identification of various Candida species, including the concerning pathogen C. auris. This medium is used to analyze samples from various body sites and fluids, and it complements standard Sabouraud agar cultures in the diagnosis of Candidiasis.